The Bloodline with Blood Cancer United Podcast Podcast By Blood Cancer United cover art

The Bloodline with Blood Cancer United Podcast

The Bloodline with Blood Cancer United Podcast

By: Blood Cancer United
Listen for free

A Podcast for Patients and CaregiversThe Bloodline with LLS - Blood Cancer United Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence

    Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence
    Mar 12 2026
    Andrew Yee, MD Multiple myeloma can feel unfamiliar and overwhelming at first, but today’s advances tell a much brighter story. In this episode, Dr. Andrew Yee of Massachusetts General Hospital explains what myeloma is, how it’s diagnosed, and why new treatment options, from four-drug regimens to CAR T-cell therapy and bispecific antibodies, are transforming patient outcomes. With enthusiasm and relatable analogies, he highlights how patients may progress from periods of significant challenges to reaching a level of stability and well‑being that allows them to live fully. This conversation offers clarity, confidence, and real optimism for anyone navigating myeloma. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Multiple myelomaAmyloidosisAutologous stem cell transplantationCAR T-cell therapyImmunotherapy fact sheetClinical Trial Support Center Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Young Adult ResourcesSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by AbbVie Inc.; Bristol Myers Squibb; Genentech, A Member of the Roche Group; GSK plc.; Johnson & Johnson. The post Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence first appeared on The Bloodline with Blood Cancer United Podcast.
    Show more Show less
    51 mins
  • Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives

    Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives
    Feb 26 2026
    CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CAR T-cell therapyClinical Trial Support CenterCAR T-Cell Therapy: A Path of Hope and Healing Video SeriesBloodline Breakthroughs: innovations and inspiration video podcast: CAR T-cell TherapyHematology Horizons vlog: CAR T-Cell Therapy and the Patient ExperienceCAR T-Cell Therapy: Side Effects video Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Young Adult ResourcesSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; Novartis Pharmaceuticals Corporation. The post Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives first appeared on The Bloodline with Blood Cancer United Podcast.
    Show more Show less
    49 mins
  • Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward

    Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward
    Feb 12 2026
    Stefan Barta, MD, MS

    Cutaneous T‑cell lymphoma (CTCL) is a rare condition that often raises important questions for patients and families.

    In this episode, we sit down with Dr. Stefan Barta, of the University of Pennsylvania, to bring clarity to what CTCL is, how it’s diagnosed, and what patients can expect from staging and treatment. Dr. Barta breaks down the differences between CTCL subtypes, explains why diagnosing someone can take time, and shares the most up-to-date therapies, including skin directed treatments, immunotherapies, and emerging clinical trial options. Most importantly, he offers reassurance for those newly diagnosed: “The future is absolutely bright… there is a lot of hope for our patients with CTCL.”

    DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey.

    Mentioned on this episode:

    • Cutaneous T-cell lymphoma
    • Cutaneous Lymphoma Foundation
    • Clinical Trial Support Center

    Additional Blood Cancer United Support Resources:

    • Free Nutrition Consultations
    • Information Specialists
    • Financial support
    • Online Chat
    • Free telephone/web patient programs
    • Free booklets
    • Young Adult Resources
    • Support groups
    • Caregiver support
    • Caregiver Workbook
    • Survivorship Workbook
    • Advocacy and Public Policy
    • Patient Community
    • Mental Health Resources

    Episode supported by Kyowa Kirin, Inc. and Cutaneous Lymphoma Foundation.

    The post Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward first appeared on The Bloodline with Blood Cancer United Podcast.
    Show more Show less
    38 mins
No reviews yet